Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans

Therapeutic Drug Monitoring

Volumn 26, Issue 6, 2004, Pages 664-672

  Kim, Insook ^a   Oyler, Jonathan M ^a   Moolchan, Eric T ^a   Cone, Edward J ^b   Huesitis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b ConeChem Research ^*  (United States)

Author keywords

Amphetamine; Excretion; Methamphetamine; Pharmacokinetics; Urine

Indexed keywords

AMPHETAMINE; DESOXYN GRADUMET; DRUG METABOLITE; METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; KIDNEY CLEARANCE; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SUSTAINED RELEASE FORMULATION; URINALYSIS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; AMPHETAMINE; AREA UNDER CURVE; FEMALE; HUMANS; MALE; METHAMPHETAMINE;

EID: 9644262384     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200412000-00013     Document Type: Article

References (22)

1. Perez-Reyes M, White WR, McDonald SA, et al. Clinical effects of daily methamphetamine administration. Clin Neuropharmacol. 1991;14:352-358.
2. Physicians' Desk Reference. Desoxyn Tablets. Physicians' Desk Reference, Oradell, NJ: Medical Economics, 2003:441-442.
3. Leshner AI. Methamphetamine. NIDA Community Drug Alert Bull. 1998:1-3.
4. 14C] methamphetamine in man, the guinea pig and the rat. Biochem J. 1972;129:11-22.
5. Beckett AH, Rowland M. Urinary excretion of methylamphetamine in man. Nature. 1965;206:1260-1261.
6. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos. 1993;21:717-723.
7. Cook CE, Jeffcoat AR, Sadler BM, et al. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos. 1992;20:856-862.
8. Baselt RC. ed. Disposition of Toxic Drugs and Chemicals in Man, 2nd ed. Davis: Biomedical Publications, 1978:488-490.
9. Kraemer T, Maurer HH. Determination of amphetamine, methamphetamine and amphetamine-derived designed drugs or medicaments in blood and urine. J Chromatogr. 1998;713:163-187.
10. Caldwell J. The metabolism of amphetamines in mammals. Drug Metab Rev. 1976;5:219-280.
11. Moffat AC, Jackson JV, Moss MS, et al. eds. Clarke's Isolation and Identification of Drugs. London: The Pharmaceutical Press, 1996:349-351.
12. Schepers RJF, Oyler JM, Joseph RE Jr, et al. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003;49:121-132.
13. Gunne LM, Anggard E. Pharmacokinetic studies with amphetamines - relationship to neuropsychiatrie disorders. J Pharm Biopharmac. 1973;1:481-495.
14. Cone EJ, Weddington W W Jr. Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Anal Toxicol. 1989;13:65-68.
15. Oyler JM, Cone EJ, Joseph RE Jr, et al. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem. 2002;48:1703-1714.
16. Oyler J, Darwin WD, Preston KL, et al. Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users. J Anal Toxicol. 1996;20:453-462.
17. Ballantyne B, Marrs TC, Syversen T. General and Applied Toxicology. New York: Grove's Dictionaries, 1999:332.
18. Elliott JS, Shart RF, Lewis L. Urinary pH. J Urol. 1959;81:339-343.
19. SAMHSA's Workplace Resource Center. Urine Specimen Validity Testing: Evaluation of the Scientific Data Used to Define Specimen as Substituted. http://workplace.samhsa.gov/ResourceCenter/r381.htm. Accessed 2004.
20. Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965;17:628-638.
21. Shargel L, Yu A. eds. Applied Biopharmaceutics & Pharmacokinetics. Stamford, CT: Appleton & Lange, 1999:326-328.
22. Comer SD, Hart CL, Ward AS, et al. Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl). 2001;155:397-404.